Skip to content
FrontierPicks

Dossier · WIX · Dormant

WIX · Wix.com Ltd. · Stock research

MEDIUM Special situation Catalyst · AI enterprise software

Last analysed ·

Against its published line

The red mark is the published kill line. The dot is where the name closed on 7 August 2026. Distance is drawn on a square-root scale, so the first two points of cushion take half the track and a name sitting on its line is legible; past 8% a name reads simply as well clear. A trigger written on weekly closes is graded on weekly closes, so a name trading through such a line mid-week reads as pending, not hit.

WIXWix.com Ltd.
$52.00
$60.20
+15.8%well clear

Resolved Graded and closed 2026-08-20 at medium conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-08-23 and is not part of the scored record.

Current thesis

Base44 margin inversion is the live leg and the market is now paying up for it: after the 2026-08-04 beat ($563.1M, +15%; adj EPS $1.39 vs $1.16) and the ~60% 2H gross-margin guide, price ran from the 2026-08-07 close of $60.20 to $66.14 on 2026-08-11, far above the $51.56 50-day. No company proof point until the ~November print, and a securities class action over Base44 cost disclosure has a 2026-09-22 lead-plaintiff deadline in between.

Kill line

A weekly close below $52 fills the 2026-08-04 earnings gap and returns price to the pre-print base, which now overlaps the rising 50-day average at $51.56; secondary, Q3 bookings growth printing under Q2's +12% or an FY26 cut from low-teens bookings growth.

Pick status

Played out resolved published kill line did not fire How this is scored →

Latest analysis and events for WIX —

As of 24 August 2026, the latest FrontierPicks analysis for Wix.com Ltd. (WIX): Base44 margin inversion is the live leg and the market is now paying up for it: after the 2026-08-04 beat ($563.1M, +15%; adj EPS $1.39 vs $1.16) and the ~60% 2H gross-margin guide, price ran from the 2026-08-07 close of $60.20 to $66.14 on 2026-08-11, far above the $51.56 50-day. No company proof point until the ~November print, and a securities class action over Base44 cost disclosure has a 2026-09-22 lead-plaintiff deadline in between.

Kill line: A weekly close below $52 fills the 2026-08-04 earnings gap and returns price to the pre-print base, which now overlaps the rising 50-day average at $51.56; secondary, Q3 bookings growth printing under Q2's +12% or an FY26 cut from low-teens bookings growth.

Next dated event on file: — catalyst today.

Price reference for this update: the 2026-08-21 close of $82.07, against the $66.14 quote used in the 2026-08-11 note. 50-day average $55.42, 200-day average $77.62, average published analyst target $77.45 (stockanalysis.com, retrieved 2026-08-23). RSI(14) 74.3. The stock sits 55.5% below its 52-week high of $184.24 and is up 54.3% over three months.

WIX — Wix.com Ltd.

Current Thesis

The narrative on offer has not changed since the 2026-08-11 note — Base44's margin inversion, priced into a float the company itself shrank — but the stock has done two things it had not done before. It reclaimed the 200-day average at $77.62, closing $82.07 on 2026-08-21, the first time price has traded above that line since the multi-quarter de-rating. And it ran past the sell-side: the average published target is $77.45, below spot, after a re-marking wave that ran from seven target revisions in the single session of 2026-08-05 through Citi's move to $72 from $59 on 2026-08-12 and Wedbush's raise to $80 (Neutral) reported 2026-08-20.

The new company-level input since the last update is Symphony by Wix, launched 2026-08-11: a standalone, platform-agnostic multi-agent system for SMBs, organised around a lead agent called Maestro that assigns specialised agents for outreach, marketing, scheduling, research, finance and design (Wix press room / GlobeNewswire, 2026-08-11). Shares gained 5.9% in the afternoon session on the announcement. No revenue, ARR or pricing disclosure accompanied the launch, so it is a product datapoint rather than a financial one.

The narrative is maturing. What dates it: the fundamental news set is still the 2026-08-04 print and the ~60% 2H Base44 gross-margin guide, unchanged for three weeks; the analyst re-marking now trails price rather than leads it (average target $77.45 versus the $82.07 close); and the 2026-08-14 session — a decline of nearly 7% attributed to a tech sell-off, a reported hedge-fund exit and SaaS valuation pressure (Benzinga, 2026-08-14) — showed the move trading with the tape rather than on its own story. It is still working, but the marginal buyer is now buying a story that has been fully written up.

Bullish and bearish views on Wix.com Ltd.

The model's bull view on Wix.com Ltd. (WIX), in brief: Q2 2026 (2026-08-04) beat both lines: revenue $563.058M vs $554.444M consensus; adjusted EPS $1.39 vs $1.16 estimate. The bear view: Price is through the consensus mark. The $82.07 close on 2026-08-21 stands above the $77.45 average target and above every August revision except Benchmark's $90 and Evercore's $95; RBC sits at $60 (Sector Perform), Wells Fargo $64, UBS $66, Citi $72, Wedbush and Cantor and… Both cases follow in full.

Bull Case

  • Q2 2026 (2026-08-04) beat both lines: revenue $563.058M vs $554.444M consensus; adjusted EPS $1.39 vs $1.16 estimate. Reported revenue $563.1M, +15% YoY; ARR $1.963B, +15%; Creative Subscriptions $398.4M (+15%), Business Solutions $164.7M (+14%).
  • Base44 carries a disclosed margin target: ARR reached $150M by early May 2026, and management guided the unit to ~60% non-GAAP gross margin in 2H 2026 from near-zero entering the year, naming the in-house Base 1 LLM as the mechanism moving inference cost off third-party rails (Q2 release and call, 2026-08-04).
  • Symphony extends the surface beyond site-building (2026-08-11): a standalone agent platform sold to businesses that do not use Wix and to businesses with no website at all, which is the first product move addressing the operational layer rather than the presence layer.
  • 41,849,511 ordinary shares outstanding as of 2026-05-11. The $2.0B authorization approved 2026-01-27 runs through 2027-12-31.
  • The short base has not visibly left. Short interest reported at 8.72M shares against a float of 36.16M and 6.52 days to cover (stockanalysis.com, 2026-08-23), against 8.79M shares in the reading carried on 2026-08-11.
  • Guidance was reaffirmed into the run: Q3 2026 revenue guided to low-double-digit YoY growth, FY26 to low- to mid-teens revenue growth, low-teens bookings growth and high-teens FCF margin ex acquisition and restructuring (2026-08-04).

Bear Case

  • Price is through the consensus mark. The $82.07 close on 2026-08-21 stands above the $77.45 average target and above every August revision except Benchmark's $90 and Evercore's $95; RBC sits at $60 (Sector Perform), Wells Fargo $64, UBS $66, Citi $72, Wedbush and Cantor and Needham at $80.
  • Nothing from the company resolves until roughly November. Q3 2025 was reported 2025-11-19; on that cadence the next print lands mid-November, leaving the reaffirmed guide to carry the stock across roughly three months with no scheduled proof point.
  • Bookings growth trailed revenue growth in Q2 2026 (+12% versus +15%), and management flagged Partners softness in the same release (2026-08-04) — bookings is the forward line, and it is the slower one.
  • The reported profit is non-GAAP. Q2 2026 showed a $(76.4)M GAAP net loss against $68.2M non-GAAP net income; FCF was $52.6M, $61.2M ex-restructuring.
  • The disclosure at the centre of the bull case is under legal challenge. The N.D. Ill. Securities class action covers purchasers 2025-02-19 to 2026-05-12 and alleges AI compute and marketing costs tied to Base44 were understated and that Wix Harmony's "holes" and "missing capabilities" were material; lead-plaintiff deadline 2026-09-22. Allegations are unadjudicated.
  • The corporate bid was spent high. Roughly $1.617B of the $2.0B authorization went out at $92.00 on 2026-04-03, leaving materially less capacity to support the stock than the headline number implies.
  • The tape can take it back without company news — demonstrated on 2026-08-14, when the stock fell nearly 7% on a sector move with no Wix-specific release.

Setup & Price Structure

  • The 2026-08-21 close of $82.07 clears the 200-day average of $77.62 — the structural event of the past two weeks, and the level whose reclaim the current move is arguing is durable.
  • The 50-day average is $55.42, far beneath price; the last touch of anything like it was the pre-print base. The gap between spot and the shorter average is the mechanical definition of an extended leg.
  • RSI(14) at 74.3 places the name in overbought territory on the daily series as of 2026-08-21.
  • The only pullback inside the leg was 2026-08-14, a decline of nearly 7% that was bought back within four sessions.
  • Crowding observables, stated as observables: short interest 8.72M shares on a 36.16M float with 6.52 days to cover; ten published target revisions between 2026-07-30 and 2026-08-20, all clustered after the print; price above the average of those targets; retail-facing coverage running headlines of the "why is Wix soaring / why is Wix falling" shape on 2026-08-11 and 2026-08-14. Insider activity is unreadable here by construction — as an Israeli foreign private issuer Wix files 20-F/6-K and its insiders are exempt from Section 16, so Form 4 screens return nothing.
  • Overhead reference: the 52-week high is $184.24; the current close is 55.5% beneath it, so the reclaim being tested is of a moving average, not of a prior high.

Catalyst Calendar (next 30 days)

  • ~2026-08-26 (est.) — Semi-monthly short-interest publication covering the 2026-08-14 settlement date. First hard reading on whether the short base covered into the August advance or was rebuilt against it.
  • ~2026-09-03 (est.) — September technology-conference season. Wix has appeared at Citi Global TMT in prior years; no 2026 participation was announced as of 2026-08-23. A fireside would be the only management commentary between the 2026-08-04 print and Q3 results.
  • ~2026-09-11 (est.) — Short-interest publication covering the 2026-08-31 settlement date. Two consecutive post-print readings are what make the first interpretable.
  • 2026-09-22 — Lead-plaintiff deadline in the N.D. Ill. Securities class action (class period 2025-02-19 to 2026-05-12). Consolidation and lead-counsel appointment follow, moving the Base44 cost-disclosure allegations onto a docket ahead of the Q3 print.

Beyond the window: ~2026-11-17 (est.) Q3 2026 results, on the Q3 2025 reporting date of 2025-11-19.

What Would Change Our Mind

The structural claim this update rests on is the reclaim of the 200-day average at $77.62 — everything else about the leg was already visible on 2026-08-11. A failed reclaim is what breaks it: a weekly close below $72 puts price back beneath that line with room to spare and unwinds the entire post-Symphony advance, at which point the August move reads as an overshoot of a well-telegraphed re-rating rather than the start of a new range.

Three non-price conditions would do the same work on the fundamentals. First, Q3 bookings growth printing under Q2's +12%, or the FY26 low-teens bookings guide being cut — bookings decelerating while Partners softness persists removes the forward line the guide depends on. Second, Base44 gross margin landing materially below the guided ~60% at the Q3 disclosure, or the metric quietly leaving the disclosure set, which would retire the specific claim the August re-rating paid for. Third, the theme moving to saturated: successive target revisions arriving with price already above them and no new demand appearing on the follow-through, which is close to what the 2026-08-20 Wedbush raise to $80 into an $82.07 tape already looks like.

The conditions that would strengthen the read are equally specific: a short-interest report on or around 2026-08-26 showing the base rebuilt above 8.72M shares while price holds the 200-day, or a September conference appearance in which management updates Base44 margin progress ahead of the November print.

Correlation Notes

  • Israeli-domiciled issuer. Israeli tech listings have repriced as a bloc on regional headlines irrespective of company results; a day where the TA-125 and Israeli ADRs gap together and WIX moves with them without company news is the signature to watch.
  • SMB web-presence and SaaS complex — GoDaddy, Squarespace, Shopify. The 2026-08-14 decline was explicitly attributed to a tech sell-off and SaaS valuation pressure rather than anything Wix-specific (Benzinga, 2026-08-14), which places the name inside that beta rather than outside it.
  • AI application layer. The bull case is a cost-of-inference story — Base 1 replacing third-party model spend — so the name trades with sentiment on whether application-layer companies can own their own inference economics.
  • High-short-interest cohort. With 8.72M shares short and 6.52 days to cover, the name carries the reflexivity of that group: it participates in squeeze tapes on the upside and in forced de-grossing on the downside, as the 2026-08-14 session showed.

Notes

  • Israeli foreign private issuer: reports on 20-F/6-K, not 10-Q/10-K, and insiders are Section 16 exempt — Form 4 insider screens return nothing on this name by construction.
  • Share count fell ~29.7% via the tender completed 2026-04-03; per-share comparisons spanning that date are not like-for-like.
  • Float readings here are vendor-dependent: the same source showed 28.60M on 2026-08-11 and 36.16M on 2026-08-23, which moves any short-percent-of-float figure materially.
  • Capital structure includes 0.00% convertible senior notes due 2030, which the $2.0B board authorization may repurchase alongside common shares.
  • GAAP and non-GAAP diverge materially: Q2 2026 showed a $(76.4)M GAAP net loss against $68.2M non-GAAP net income.
  • A securities class action (N.D. Ill.) covers purchasers 2025-02-19 to 2026-05-12; allegations are unadjudicated and no lead plaintiff has been appointed.

Related · shared themes

OKTA

Okta, Inc.

Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme accelerating, this leg maturing; open risk is paying up for a stretched 52-week-high tape.

MEDIUM

HNGE

Hinge Health, Inc.

Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.

LOW

HPE

Hewlett Packard Enterprise Company

The one green close failed: 2026-08-24 closed $52.43, undercutting the 08-20 low close of $52.89 and marking seven of eight sessions lower off the 2026-08-13 high of $59.82, with no dated HPE news since 2026-08-19. The 2026-09-02 Q3 print is the binary — screens carry ~$0.93–0.94 EPS on ~$11.97B against a $0.88–0.93 / $11.5–12.1B guide. The narrative is saturated.

LOW

SNX

TD SYNNEX Corporation

Second-order AI re-rating still unconfirmed by company data, and the tape has now taken it back: the 2026-08-24 close of $243.65 leaves a three-month price change of +1.7% with RSI(14) at 27.3. The 11-analyst panel has not revised since 2026-07-22, across five external events. NVDA on 2026-08-26 re-prices the complex a month before TD SYNNEX discloses anything.

LOW

See also · stocks to watch